STOCKHOLM, July 1, 2024 /PRNewswire/ -- IFPA (The
International Federation of Psoriasis Associations) concluded its
highly anticipated 7th IFPA Conference on World Psoriasis and
Psoriatic Arthritis, held from June 27 to
29, 2024, in Stockholm,
Sweden. Established in 2006, the conference has become a
cornerstone event for medical and health professionals worldwide,
fostering collaboration and showcasing cutting-edge research in
dermatology, rheumatology, and related fields.
Under the theme "Uncovering the Broad Spectrum of Psoriatic
Disease," this year's conference aimed to foster international
collaboration on research, advocacy initiatives, and awareness
among medical professionals and industry stakeholders.
Delegates from over 76 countries convened at the IFPA Conference
2024, representing a diverse array of clinical experts, health
professionals, and patient organizations. Accredited by the
European Accreditation Council for Continuing Medical Education
(EACCME), the conference featured over 190 abstracts covering
pivotal topics such as biomarkers, imaging, and comorbidities.
A highlight of the conference was the recognition of exceptional
e-posters through the Poster Prize. The event also showcased over
50 high-level presentations, spotlighting cutting-edge research and
advancements in the field of psoriatic disease.
Professor April Armstrong,
Conference President, remarked on the conference's impact: "We
shared knowledge, engaged in meaningful conversations, and
highlighted significant achievements in the prevention, diagnosis,
and treatment of psoriatic disease. The IFPA conference serves as a
platform to focus on future research and advance care for all
persons living with psoriatic disease."
Ingvar Ágúst Ingvarsson, Acting President of IFPA, highlighted
the conference's theme: "'Uncovering the Broad Spectrum of
Psoriatic Disease' emphasized patient-focused research and
encouraged collaborations on future advocacy initiatives. We warmly
welcome you all to the next IFPA World Conference in 2027."
Barbra Bohannan, Conference
Secretary, reflected on the conference's success: "The 2024 IFPA
conference showcased our progress in treating the whole person,
highlighting the complex nature of psoriatic disease and inspiring
hope for improved quality of life."
Frida Dunger, Executive Director
of IFPA, expressed gratitude: "During the past three days, we have
united the psoriatic disease community and truly covered the broad
spectrum of this disease. We are bridging gaps between disciplines,
specialty groups, and the patient community, moving from knowledge
to action. Thank you to everyone who contributed to the success of
the 7th IFPA Conference."
IFPA remains committed to advancing medical knowledge and
improving patient care through future conferences and
initiatives.
If you couldn't make it to the conference, register at
https://conference.ifpa-pso.com/register to get access to the
virtual program.
For more information about the conference,
visit ifpaconference.com.
Photo:
https://mma.prnewswire.com/media/2447455/IFPA_Conference.jpg
Media contact:
Annika Sjöberg
annika.sjoberg@ifpa-pso.com
+46 (0) 70 749 58 20
View original
content:https://www.prnewswire.co.uk/news-releases/ifpa-celebrates-success-of-the-7th-ifpa-conference-2024-302181684.html